High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma

To assess the efficacy of HDC with AHCT versus standard-dose chemotherapy in improving event-free survival, overall survival, quality adjusted survival and progression-free survival of children, adolescents and young adults with first recurrence of ES and to determine the toxicity of the treatment.

This is a protocol.

Share/Save